Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome
- 27 July 2000
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 2 (4) , 260-268
- https://doi.org/10.1002/1521-2254(200007/08)2:4<260::aid-jgm111>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirusGene Therapy, 1999
- Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorNature Medicine, 1999
- Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsNature Medicine, 1999
- Novel Tools for Production and Purification of Recombinant Adenoassociated Virus VectorsHuman Gene Therapy, 1998
- High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle VirusHuman Gene Therapy, 1998
- Adeno-associated virus vectors can be efficiently produced without helper virusGene Therapy, 1998
- Factors Influencing Recombinant Adeno-Associated Virus ProductionHuman Gene Therapy, 1998
- A New Strategy for Large-Scale Preparation of High-Titer Recombinant Adeno-Associated Virus Vectors by Using Packaging Cell Lines and Sulfonated Cellulose Column ChromatographyHuman Gene Therapy, 1996
- Cell Lines for the Production of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1995
- The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex.Molecular and Cellular Biology, 1994